We found that genetic ablation of the p65 subunit of NF-κB attenuated the expression of YY1 and downstream target MMP-14, shedding light on a potential approach to regulate the MMP-14 expression in gastric cancer. The gene discussed is NFKB1; the disease is gastric cancer.